Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hollywood in on the action - Belushi's Farm!
https://twitter.com/JimBelushi/status/1413216614451924999/photo/1
Check this pic out: Belushi's Farm!
https://twitter.com/JimBelushi/status/1413216614451924999/photo/1
Check. Thanks Ahab. I remember you from the ONCS days.
I'm not too sure any more about this company. Go ahead hire a director. And what do they hire after all this gnashing of teeth? I don't know. And I don't think anyone can say for sure, at this moment.
If they would have hired a director that says this: "there is no misunderstanding I wouldn’t piss on you guys if you were on fire." Now that is saying something.
Leronlimab is a definite. Now we wait to see what our new director will say...
Just say something definite. Don't indicate anything by pointing three fingers.
OMG. up by 4 cents. Yay.
Time to switch brokers.
It was a post to all on the board
Anybody know what this is about? Maybe a little good news?
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=cytodyn.ASNM.&OS=AN/cytodyn&RS=AN/cytodyn
Cracks in the armor...
First of all, I am talking about Covid. Ten years of mounting mistakes does not include Covid. If he had as many mounting mistakes as you point out, he would not have been able to do this trial. IMO
Do you have any idea what it takes to write an HIV/BLA application? Write a successful one? Just asking...
I don't see many companies doing that... so I am going to err on the side of, it must be difficult.
Make no mistake, I believe NP is a bumbler and every time there is a webcast and he speaks, I am under a Nader proof rock, but, I think you are making light of the application process. Maybe he sought qualified people and had no takers...
So this is what we NOW know: the Long Haulers in the LH trial who were given Leronlimab fared much better than the ones who were given a placebo.
We also NOW know that those patients who were given Leronlimab were temporarily healed of most of their symptoms. Some have recently stated that symptoms are returning. So Leronlimab does work - just like we thought before the FDA letter - some have believed in LL for more than five years.
Why am I stating this? Because, instead of highlighting LL's benefits, we keep reading about NP's shortcomings.
Furthermore, I would like to ask, when was the last time that there was an efficacious therapy for Long Haulers?
I know that is really a stupid question but hear me out.
Of course, the answer is: Covid has been around for only eighteen months. So there hasn't been an efficacious therapy for Long Haulers. Besides, maybe since October of 2020 have some in the medical field acknowledged that there is a malady called "Long Haulers."
This begs the question: has the FDA seen this type of malady before?
Another stupid question but it must be asked.
No, the FDA has not seen this type of malady.
So what are the protocols for this malady - (I think it's called PASC).
Again there are none, yet. They're coming, but not here yet.
The FDA recently spanked CytoDyn for claiming endpoints that do not exist but if the FDA does not have protocols in place for PASC, which is in CytoDyn's wheelhouse, how can it justify that critique?
Furthermore why criticize NP when we are standing on the threshold of an undiscovered malady with no protocols in place. Is it possible that it is not NP's fault? He looks like he is bumbling around but that's because the FDA is bumbling MORE.
The protocols for PASC are now going to be initialized/authorized due to the FACT of this trial. CytoDyn's trial.
Did NP have anything to do with this trial?
My point is: all those who have been critical of NP in the past have placed the cart before the horse.
This PASC hell-hole was recently dense wilderness until Leronlimab. The FDA is about to clear a path due to NP, CytoDyn's workforce, and the Long Haulers who participated in the first ever trial.
Look how long that took, or short depending on one's optimism or pessimism.
In conclusion, NP is not the problem. Read on: The Pharma Industry is highly-regulated. Protocols are put in place to keep people safe. It takes much time, bureaucratically, to ensure a drug is safe.
NP has taken the first step - took quite a bit of time despite the enormous pressure to get things done. Now we want him to file BLA's and start other trials - just remember this is a highly regulated industry. NP is beholden to regulations and a myriad of rules.
Be safe.
Another Long Hauler, Erma, shares her message:
Jumping in to answer any questions about my post from the main investor page. I was in CD12 last year (Sep) and started the first week of CD15 in early March. First set of shots 0310, last - sadly- 0429. I do know my status, but will wait for all to be reported in GA. Having experienced LL last year, I had an advantage in knowing how my body reacts. I am looking forward to participating in my 3rd trial when CD19 gets approved (being very optimistic - I know Chris will succeed. His entire heart, mind and soul are devoted to Leronlimab and it's success at treating patients). IMHO, CYDY's best move was to bring Dr. Recknor on as COO. Thanks to Miranda Erlanson & Rebecca Sanders for starting this very specific group! Thanks Chris Lonsford for setting it up. Good discussions will come from here ??(and I have to give a special shout out to Burke Hill who so long ago invited me to the investor page!)
Miranda who was in the Long Hauler's trial and given the CytoDyn drug, Leronlimab, had this to say about her experience:
I’m going to share a few updates on some of the clinical trial participants. To be clear, many symptoms went away or finished greatly with Leronlimab. Weeks after I finished my treatment, some symptoms did return but in a 300% diminished capacity. Leronlimab helped my POTS, small fiber neuropathy, tingling and numbness, vomiting (controlled for 14 weeks, received LL for 8 weeks). Brain fog went away completely, but returned very diminished. Fevers returned but only sporadically, more mild temperature. I no longer depend on my wheelchair due to direct weakness, atrophy, Guillain Barre, or muscle dystrophy. I only rarely use it now if I have heart and POTS pains and issues. So many things are better, but I need more Leronlimab to control some of the symptoms that did return.
For me Leronlimab has been a gold star!
RP, you could not have described it any better.
Thank you for the FCEL list.
Love it. Thanks for posting it.
Is this your IMO or did you hear it?
Good answer, Misui! NP is learning.
Yeh, I'm tired of you not posting all the information. Let's try this for real. Here's your posting on Valens:
COMPARISON VALENS VS TILT HOLDINGS
The Valens Group VLNCF
Last quarterly revenue $20.0M
Adjusted EBITDA <$2.2M>
Shares outstanding 159,747,768
Net loss/gain <$5,647,000 >
Cash and cash equivalent $43.3M
Price per share $2.53
TILT Holdings TLLTF
Last quarterly revenue $46.8M
Adjusted EBITDA $6.2M
Shares outstanding 325,668,294
Net loss/gain <$1,500,000>
Cash and cash equivalent $9M
Price per share $0.50
The poster on Valens said, "Hey, where's the debt?" Did you answer? Hell, no!
He answered for you.
TILT has 87 million debt compared to Valens 13 million.
I'll take Valens over TILT.
You tired this with Valens and NOT!
Name one Covid therapeutic drug that gained approval in 2020. We had no chance to run a trial with Gilead. Why team up with another drug when Gilead had the entire spotlight focused on them?
And nice volume too!
Wink wink.
Lots of changes, UP!
"We have likely missed the COVID play."
This description is fast becoming the de-facto line for LL. AND it is so untrue.
Less than 53% of the US population is fully vaccinated. And, judging from all the good/researched comments about the efficacy of vaccinations, my bet is that we are in the second inning of a loooooooong Covid game.
There is such ignorance about vaccinations that if anyone who is fully vaccinated believes that they don't have to wear a mask, especially when LL has not been approved for EUA, good luck with your healthy life.
Ask Eli Musser and a few others who were fortunate to have been inoculated with LL and claimed their life again.
I don't want to get the new Covid strain especially since there is CURRENTLY no known therapeutic that does what LL does beautifully. All these pharmas are trying and the FDA is allotting plenty of time so that they may develop a therapeutic like that recently approved Biogen drug.
Except for the fact that the Biogen drug is for dementia not Covid.
As I said, we are in the second inning of a long Covid game. A serious adversary. We have to win somewhere at some stage. Odds/greater numbers will dictate otherwise.
GTI falling at the same rate as Tru. Cresco not far behind.
That's what one would call sardonic humor. ER.
Very helpful. Thank you.
Isn't it a requisite that the share price be above $5 at the time of listing on the Nasdaq?
It's news, which was reported yesterday on TV.
Not paid promotion.
This is amazing. Too bad it's Saturday and not Wednesday.
There are plenty that say CYDY is a farce. There are plenty that hate the CEO, Nader.
But, let's keep things really clear. CYDY and Nader are NOT Leronlimab - that is the drug that CYDY and Nader have in common - they own it.
If you don't know anything about Leronlimab, do not research CYDY or Nader! Huh?
That's right.
Look up information solely on Leronlimab. It works. It helps people get back on their feet, like COVID long-hauler syndrome.
Like right here - which it has been doing since 2019. NO ONE can dispute it. No one.
"you can be altruistic or you can make money...trying to do both at the same time constrains you and makes investing just that much harder... "
I believe the Wright brothers were being altruistic...
That's a good plan.
Obviously your strategy is to make a profit in a trading range.
There are some here that do not trade for a living: they have another job unrelated to the stock market.
They are actually buying the stock and holding. This is probably an altruistic and old
strategy but nonetheless, it is real.
Electricity is sexy. Hydrogen is confusing to most. But after the earning release, a headline:
The US hydrogen moonshot
He's saying that the poster has developed a new breed of stinkweed.